Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia

The SCAP method

Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, Toshiya Inada, Takashi Yoshio, Reiji Yoshimura, Nakao Iwata

研究成果: Review article

抄録

Compared with other countries, Japan exhibits prominent levels of antipsychotic polypharmacy and high-dose regimens. In view of these circumstances, the Safe Correction of Antipsychotic Polypharmacy and high-dose regimens (SCAP) method was developed based on previous findings as a realistic way to reduce medication consumption in patients already experiencing polypharmacy and high-dose regimens. In the SCAP method, "clinicians can reduce medications one by one, gradually, with occasional breaks permitted." A clinical study conducted to evaluate this method found no change in clinical symptoms, side effects, or quality of life (QOL), and the number of withdrawals due to aggravation was also small. A leaflet describing these results, and which is designed to support efforts to reduce medications, has been released. Future research will involve the examination and analysis of data from this study, taking into account its limitations, with a view toward developing guidelines applicable to clinical settings. The pragmatic, gradual correction of polypharmacy and high-dose regimens that goes beyond the "multiple drugs or single agent" dichotomy can decrease the burden experienced by patients. This is a practical approach that can be applied when developing comprehensive plans for the future psychiatric care of aging patient populations.

元の言語English
ページ(範囲)305-311
ページ数7
ジャーナルSeishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
117
発行部数4
出版物ステータスPublished - 01-01-2015

Fingerprint

Polypharmacy
Antipsychotic Agents
Schizophrenia
Psychiatry
Patient Care
Japan
Quality of Life
Guidelines
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

Yamanouchi, Yoshio ; Sukegawa, Tsuruhei ; Inagaki, Ataru ; Inada, Toshiya ; Yoshio, Takashi ; Yoshimura, Reiji ; Iwata, Nakao. / Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia : The SCAP method. :: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. 2015 ; 巻 117, 番号 4. pp. 305-311.
@article{f1931512295a4662a7f7710fbca9c0f8,
title = "Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method",
abstract = "Compared with other countries, Japan exhibits prominent levels of antipsychotic polypharmacy and high-dose regimens. In view of these circumstances, the Safe Correction of Antipsychotic Polypharmacy and high-dose regimens (SCAP) method was developed based on previous findings as a realistic way to reduce medication consumption in patients already experiencing polypharmacy and high-dose regimens. In the SCAP method, {"}clinicians can reduce medications one by one, gradually, with occasional breaks permitted.{"} A clinical study conducted to evaluate this method found no change in clinical symptoms, side effects, or quality of life (QOL), and the number of withdrawals due to aggravation was also small. A leaflet describing these results, and which is designed to support efforts to reduce medications, has been released. Future research will involve the examination and analysis of data from this study, taking into account its limitations, with a view toward developing guidelines applicable to clinical settings. The pragmatic, gradual correction of polypharmacy and high-dose regimens that goes beyond the {"}multiple drugs or single agent{"} dichotomy can decrease the burden experienced by patients. This is a practical approach that can be applied when developing comprehensive plans for the future psychiatric care of aging patient populations.",
author = "Yoshio Yamanouchi and Tsuruhei Sukegawa and Ataru Inagaki and Toshiya Inada and Takashi Yoshio and Reiji Yoshimura and Nakao Iwata",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "117",
pages = "305--311",
journal = "Psychiatria et Neurologia Japonica - Seishin Shinkeigaku Zasshi",
issn = "0033-2658",
publisher = "Japanese Society of Psychiatry and Neurology",
number = "4",

}

Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia : The SCAP method. / Yamanouchi, Yoshio; Sukegawa, Tsuruhei; Inagaki, Ataru; Inada, Toshiya; Yoshio, Takashi; Yoshimura, Reiji; Iwata, Nakao.

:: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 巻 117, 番号 4, 01.01.2015, p. 305-311.

研究成果: Review article

TY - JOUR

T1 - Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia

T2 - The SCAP method

AU - Yamanouchi, Yoshio

AU - Sukegawa, Tsuruhei

AU - Inagaki, Ataru

AU - Inada, Toshiya

AU - Yoshio, Takashi

AU - Yoshimura, Reiji

AU - Iwata, Nakao

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Compared with other countries, Japan exhibits prominent levels of antipsychotic polypharmacy and high-dose regimens. In view of these circumstances, the Safe Correction of Antipsychotic Polypharmacy and high-dose regimens (SCAP) method was developed based on previous findings as a realistic way to reduce medication consumption in patients already experiencing polypharmacy and high-dose regimens. In the SCAP method, "clinicians can reduce medications one by one, gradually, with occasional breaks permitted." A clinical study conducted to evaluate this method found no change in clinical symptoms, side effects, or quality of life (QOL), and the number of withdrawals due to aggravation was also small. A leaflet describing these results, and which is designed to support efforts to reduce medications, has been released. Future research will involve the examination and analysis of data from this study, taking into account its limitations, with a view toward developing guidelines applicable to clinical settings. The pragmatic, gradual correction of polypharmacy and high-dose regimens that goes beyond the "multiple drugs or single agent" dichotomy can decrease the burden experienced by patients. This is a practical approach that can be applied when developing comprehensive plans for the future psychiatric care of aging patient populations.

AB - Compared with other countries, Japan exhibits prominent levels of antipsychotic polypharmacy and high-dose regimens. In view of these circumstances, the Safe Correction of Antipsychotic Polypharmacy and high-dose regimens (SCAP) method was developed based on previous findings as a realistic way to reduce medication consumption in patients already experiencing polypharmacy and high-dose regimens. In the SCAP method, "clinicians can reduce medications one by one, gradually, with occasional breaks permitted." A clinical study conducted to evaluate this method found no change in clinical symptoms, side effects, or quality of life (QOL), and the number of withdrawals due to aggravation was also small. A leaflet describing these results, and which is designed to support efforts to reduce medications, has been released. Future research will involve the examination and analysis of data from this study, taking into account its limitations, with a view toward developing guidelines applicable to clinical settings. The pragmatic, gradual correction of polypharmacy and high-dose regimens that goes beyond the "multiple drugs or single agent" dichotomy can decrease the burden experienced by patients. This is a practical approach that can be applied when developing comprehensive plans for the future psychiatric care of aging patient populations.

UR - http://www.scopus.com/inward/record.url?scp=84952945525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952945525&partnerID=8YFLogxK

M3 - Review article

VL - 117

SP - 305

EP - 311

JO - Psychiatria et Neurologia Japonica - Seishin Shinkeigaku Zasshi

JF - Psychiatria et Neurologia Japonica - Seishin Shinkeigaku Zasshi

SN - 0033-2658

IS - 4

ER -